BioNTech SE (22UA.F)
| Previous close | 82.95 |
| Open | 81.50 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 81.50 - 82.70 |
| 52-week range | 77.50 - 116.00 |
| Volume | |
| Avg. volume | 1,303 |
| Market cap | 19.882B |
| Beta (5Y monthly) | 0.23 |
| PE ratio (TTM) | 21.54 |
| EPS (TTM) | 3.83 |
| Earnings date | 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Jun 2022 |
| 1y target est | 334.89 |
- Reuters
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.
CityAMThis may hurt: English High Court set for Moderna and Pfizer/BioNTech Covid battle starting today
The English part of a global dispute billion dollar legal case involving big pharma giants Modern, Pfizer and BioNTech over Covid patents, kicks off today.
Insider Monkey25 Richest Billionaires in Healthcare Industry
In this article, we discuss the 25 richest billionaires in healthcare industry. To skip the detailed analysis of the healthcare industry, go directly to the 5 Richest Billionaires in Healthcare Industry. Global Healthcare Industry Outlook and Trends The global healthcare industry is going through a massive transition amid technological advancements, changing patient needs, and demographic […]
